German drugmaker Dermapharm plans March IPO - sources

FRANKFURT (Reuters) - German non-prescription drugmaker Dermapharm is planning to list on the Frankfurt stock exchange before the Easter holidays, in a deal that is expected to value the company at more than 1 billion euros ($1.2 billion), people familiar with the matter said. ‎
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news